Computed tomography findings predicting invasiveness of thymoma

Journal of Thoracic Oncology

Volumn 6, Issue 7, 2011, Pages 1274-1281

  Marom, Edith M ^a   Milito, Miguel A ^a   Moran, Cesar A ^b   Liu, Ping ^b   Correa, Arlene M ^b   Kim, Edward S ^b   Komaki, Ritsuko ^b   Erasmus, Jeremy J ^a   Hofstetter, Wayne L ^b   Rice, David C ^b   Swisher, Stephen G ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Computed tomography; Neoadjuvant therapy; Staging; Thymoma

Indexed keywords

IOVERSOL;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER INFILTRATION; CANCER INVASION; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FOLLOW UP; HUMAN; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIMARY TUMOR; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; THYMOMA; TREATMENT OUTCOME; TUMOR CLASSIFICATION; TUMOR VOLUME;

EID: 79959889911     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e31821c4203     Document Type: Article

References (48)

1. Duwe BV, Sterman DH, Musani AI. Tumors of the mediastinum. Chest 2005;128:2893-2909. (Pubitemid 41507651)
2. Suster S, Moran CA. Histologic classification of thymoma: The World Health Organization and beyond. Hematol Oncol Clin North Am 2008; 22:381-392. (Pubitemid 351726404)
3. Blumberg D, Port JL, Weksler B, et al. Thymoma: A multivariate analysis of factors predicting survival. Ann Thorac Surg 1995;60:908- 913; discussion 914.
4. Masaoka A, Monden Y, Nakahara K, et al. Follow-up study of thymomas with special reference to their clinical stages. Cancer 1981;48: 2485-2492. (Pubitemid 12228012)
5. Casey EM, Kiel PJ, Loehrer PJ Sr. Clinical management of thymoma patients. Hematol Oncol Clin North Am 2008;22:457-473. (Pubitemid 351726412)
6. Kim ES, Putnam JB, Komaki R, et al. Phase II study of a multidisciplinary approach with induction chemotherapy, followed by surgical resection, radiation therapy, and consolidation chemotherapy for unresectable malignant thymomas: Final report. Lung Cancer 2004;44:369-379. (Pubitemid 38609446)
7. Elkiran ET, Abali H, Aksoy S, et al. Thymic epithelial neoplasia: A study of 58 cases. Med Oncol 2007;24:197-201. (Pubitemid 350135971)
8. Rea F, Sartori F, Loy M, et al. Chemotherapy and operation for invasive thymoma. J Thorac Cardiovasc Surg 1993;106:543-549. (Pubitemid 23277629)
9. Venuta F, Rendina EA, Longo F, et al. Long-term outcome after multimodality treatment for stage III thymic tumors. Ann Thorac Surg 2003;76:1866-1872; discussion 1872. (Pubitemid 37510495)
10. Venuta F, Rendina EA, Pescarmona EO, et al. Multimodality treatment of thymoma: A prospective study. Ann Thorac Surg 1997;64:1585-1591; discussion 1591-1582.
11. Koga K, Matsuno Y, Noguchi M, et al. A review of 79 thymomas: Modification of staging system and reappraisal of conventional division into invasive and non-invasive thymoma. Pathol Int 1994;44:359-367. (Pubitemid 24153752)
12. Travis WD, Brambilla E, Muller-Hermelik HK, et al. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. Lyon: IARC Press, 2004.
13. Suster S, Moran CA. Thymoma, atypical thymoma, and thymic carcinoma. A novel conceptual approach to the classification of thymic epithelial neoplasms. Am J Clin Pathol 1999;111:826-833. (Pubitemid 29250114)
14. Kaplan E, Meier P. Nonparametric estimation from incomplete observation. J Am Stat Assoc 1958;53:457-481.
15. Cox DR. Regression models and life-tables. J R Stat Soc Ser B 1972; 34:187-220.
16. Gripp S, Hilgers K, Wurm R, et al. Thymoma: Prognostic factors and treatment outcomes. Cancer 1998;83:1495-1503. (Pubitemid 28465467)
17. Nakagawa K, Asamura H, Matsuno Y, et al. Thymoma: A clinicopathologic study based on the new World Health Organization classification. J Thorac Cardiovasc Surg 2003;126:1134-1140. (Pubitemid 37305702)
18. Wright CD, Wain JC, Wong DR, et al. Predictors of recurrence in thymic tumors: Importance of invasion, World Health Organization histology, and size. J Thorac Cardiovasc Surg 2005;130:1413-1421. (Pubitemid 41543213)
19. Jeong YJ, Lee KS, Kim J, et al. Does CT of thymic epithelial tumors enable us to differentiate histologic subtypes and predict prognosis? AJR 2004;183:283-289. (Pubitemid 38970313)
20. Yakushiji S, Tateishi U, Nagai S, et al. Computed tomographic findings and prognosis in thymic epithelial tumor patients. J Comput Assist Tomogr 2008;32:799-805.
21. Sadohara J, Fujimoto K, Muller NL, et al. Thymic epithelial tumors: Comparison of CT and MR imaging findings of low-risk thymomas, high-risk thymomas, and thymic carcinomas. Eur J Radiol 2006;60: 70-79. (Pubitemid 44397380)
22. Tomiyama N, Johkoh T, Mihara N, et al. Using the World Health Organization Classification of thymic epithelial neoplasms to describe CT findings. AJR 2002;179:881-886.
23. Rieker RJ, Hoegel J, Morresi-Hauf A, et al. Histologic classification of thymic epithelial tumors: Comparison of established classification schemes. Int J Cancer 2002;98:900-906. (Pubitemid 34286688)
24. Chalabreysse L, Roy P, Cordier JF, et al. Correlation of the WHO schema for the classification of thymic epithelial neoplasms with prognosis: A retrospective study of 90 tumors. Am J Surg Pathol 2002;26: 1605-1611. (Pubitemid 35387223)
25. Chen G, Marx A, Wen-Hu C, et al. New WHO histologic classification predicts prognosis of thymic epithelial tumors: A clinicopathologic study of 200 thymoma cases from China. Cancer 2002;95:420-429. (Pubitemid 34787609)
26. Girard N, Mornex F, Van Houtte P, et al. Thymoma: A focus on current therapeutic management. J Thorac Oncol 2009;4:119-126.
27. Tomiyama N, Muller NL, Ellis SJ, et al. Invasive and noninvasive thymoma: Distinctive CT features. J Comput Assist Tomogr 2001;25: 388-393. (Pubitemid 32440791)
28. Priola AM, Priola SM, Di Franco M, et al. Computed tomography and thymoma: Distinctive findings in invasive and noninvasive thymoma and predictive features of recurrence. Radiol Med 2010;115:1-21.
29. Falkson CB, Bezjak A, Darling G, et al. The management of thymoma: A systematic review and practice guideline. J Thorac Oncol 2009;4: 911-919.
30. Kondo K, Monden Y. Therapy for thymic epithelial tumors: A clinical study of 1,320 patients from Japan. Ann Thorac Surg 2003;76:878-884; discussion 884-875. (Pubitemid 37100765)
31. Rena O, Papalia E, Oliaro A, et al. Does adjuvant radiation therapy improve disease-free survival in completely resected Masaoka stage II thymoma? Eur J Cardiothorac Surg 2007;31:109-113. (Pubitemid 44880769)
32. Singhal S, Shrager JB, Rosenthal DI, et al. Comparison of stages I-II thymoma treated by complete resection with or without adjuvant radiation. Ann Thorac Surg 2003;76:1635-1641, discussion 1641-1632.
33. Wilkins EW Jr, Grillo HC, Scannell JG, et al. J. Maxwell Chamberlain Memorial Paper. Role of staging in prognosis and management of thymoma. Ann Thorac Surg 1991;51:888-892.
34. Myojin M, Choi NC, Wright CD, et al. Stage III thymoma: Pattern of failure after surgery and postoperative radiotherapy and its implication for future study. Int J Radiat Oncol Biol Phys 2000;46:927-933. (Pubitemid 30114406)
35. Adams MJ, Hardenbergh PH, Constine LS, et al. Radiation-associated cardiovascular disease. Crit Rev Oncol Hematol 2003;45:55-75. (Pubitemid 35449788)
36. Boivin JF, Hutchison GB, Lubin JH, et al. Coronary artery disease mortality in patients treated for Hodgkin's disease. Cancer 1992;69: 1241-1247.
37. Brosius FC 3rd, Waller BF, Roberts WC. Radiation heart disease. Analysis of 16 young (aged 15 to 33 years) necropsy patients who received over 3,500 rads to the heart. Am J Med 1981;70:519-530. (Pubitemid 11154072)
38. Corn BW, Trock BJ, Goodman RL. Irradiation-related ischemic heart disease. J Clin Oncol 1990;8:741-750. (Pubitemid 20127260)
39. Hancock SL, Donaldson SS, Hoppe RT. Cardiac disease following treatment of Hodgkin's disease in children and adolescents. J Clin Oncol 1993;11:1208-1215. (Pubitemid 23199121)
40. Heidenreich PA, Schnittger I, Strauss HW, et al. Screening for coronary artery disease after mediastinal irradiation for Hodgkin's disease. J Clin Oncol 2007;25:43-49. (Pubitemid 350003049)
41. Jingu K, Kaneta T, Nemoto K, et al. The utility of 18F-fluorodeoxyglucose positron emission tomography for early diagnosis of radiationinduced myocardial damage. Int J Radiat Oncol Biol Phys 2006;66: 845-851. (Pubitemid 44436708)
42. Joensuu H. Acute myocardial infarction after heart irradiation in young patients with Hodgkin's disease. Chest 1989;95:388-390. (Pubitemid 19051423)
43. Joensuu H. Myocardial infarction after irradiation in Hodgkin's disease: A review. Recent Results Cancer Res 1993;130:157-173.
44. Paszat LF, Mackillop WJ, Groome PA, et al. Mortality from myocardial infarction following postlumpectomy radiotherapy for breast cancer: A population-based study in Ontario, Canada. Int J Radiat Oncol Biol Phys 1999;43:755-762.
45. Paszat LF, Vallis KA, Benk VM, et al. A population-based case-cohort study of the risk of myocardial infarction following radiation therapy for breast cancer. Radiother Oncol 2007;82:294-300. (Pubitemid 46341476)
46. Adams MJ, Lipshultz SE. Pathophysiology of anthracycline- and radiation- associated cardiomyopathies: Implications for screening and prevention. Pediatric Blood Cancer 2005;44:600-606. (Pubitemid 40629208)
47. Schimmel KJ, Richel DJ, van den Brink RB, et al. Cardiotoxicity of cytotoxic drugs. Cancer Treat Rev 2004;30:181-191. (Pubitemid 38418056)
48. Travis LB, Boice JD Jr, Travis WD. Second primary cancers after thymoma. Int J Cancer 2003;107:868-870.